[P2–055]: PHARMACOLOGICAL CHARACTERIZATION OF BAN2401‐MEDIATED Aβ PROTOFIBRIL CLEARANCE BY MICROGLIA

MLA

Lars Lannfelt, et al. “[P2–055]: PHARMACOLOGICAL CHARACTERIZATION OF BAN2401‐MEDIATED Aβ PROTOFIBRIL CLEARANCE BY MICROGLIA.” Alzheimer’s & Dementia, vol. 13, July 2017. EBSCOhost, https://doi.org/10.1016/j.jalz.2017.06.704.

APA

Lars Lannfelt, Malin Johannesson, Chad J. Swanson, Veronika Logovinsky, Andrew Satlin, Christer Möller, & Linda Söderberg. (2017). [P2–055]: PHARMACOLOGICAL CHARACTERIZATION OF BAN2401‐MEDIATED Aβ PROTOFIBRIL CLEARANCE BY MICROGLIA. Alzheimer’s & Dementia, 13. https://doi.org/10.1016/j.jalz.2017.06.704

Chicago

Lars Lannfelt, Malin Johannesson, Chad J. Swanson, Veronika Logovinsky, Andrew Satlin, Christer Möller, and Linda Söderberg. 2017. “[P2–055]: PHARMACOLOGICAL CHARACTERIZATION OF BAN2401‐MEDIATED Aβ PROTOFIBRIL CLEARANCE BY MICROGLIA.” Alzheimer’s & Dementia 13 (July). doi:10.1016/j.jalz.2017.06.704.